DRUGS FOR SYMPTOMATIC TREATMENT OF HUNTINGTON'S DISEASE: A NEURODEGENERATIVE DISORDER
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 6
Abstract
Huntington’s disease is a devastating inherited neurodegenerative disease characterized by progressive motor, cognitive, and psychiatric symptoms. Patients may present with any of these symptoms, and familiarity with the phenotype is therefore important. Chorea and loss of balance are early symptoms that patients notice, although families often notice cognitive or personality changes before this. Although no therapy is currently available to delay the onset of symptoms or prevent the progression of the disease, symptomatic treatment of patients with Huntington disease (HD) may improve the quality of life and prevent complications. As is the case with other neurological diseases, HD makes individuals more vulnerable to side effects from medications, particularly cognitive adverse effects. Symptomatic treatment for HD can be divided into drugs to treat the movement disorder and drugs to treat psychiatric or behavioral problems. Symptomatic treatment of Huntington’s disease involves use of Dopamine antagonists, presynaptic dopamine depleters, Antidepressants, Tranquillizers, Anxiolytic Benzodiazepines, Anticonvulsants and Antibiotics. Several medications including baclofen, idebenone and vitamin E have studied in clinical trials with limited samples. This article reviews current therapeutic agents for treatment of the symptoms of Huntington’s disease. The aim of present article is to provide in depth knowledge about symptomatic treatment and other therapies involved in the management of Huntington’s disease.
Authors and Affiliations
Pranab Prakash Panigrahi*| Executive, QC (Stability), Aurobindo Pharma Ltd., Mahaboob Nagar, Andhra Pradesh, India-509302
Keywords
Related Articles
- EP ID EP2352
- DOI -
- Views 317
- Downloads 22
PRELIMINARY SCREENING OF SECONDARY METABOLITES AND BRINE SHRIMP LETHALITY BIOASSAY OF WARM-WATER EXTRACT OF PUFFER FISH ORGANS TISSUES, TETRAODON CUTCUTIA, AVAILABLE IN BANGLADESH.
This study is aimed to establish the invitro screening of secondary metabolites namely alkaloids, steroids, alcoholic compounds, glycosides, and amide group containing compounds from warm-water extracts of puffer fish d...
CLINICO-ETIOLOGICAL STUDY OF NEONATAL JAUNDICE IN A TERTIARY CARECENTRE IN AMBALA (HARYANA) INDIA
Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the potential toxicity of bilirubin, newborn infants must be monitored to identify those who might develop severe hyperbilirubinemia and, i...
A REVIEW ON ROLE OF PERIDURAL FIBROSIS AND ITS DIAGNOSIS
FBSS is a challenging clinical entity with significant impact on the individual and society. To better prevent and manage this condition, knowledge of the factors contributing to its development is necessary. While resea...
UNDISPUTABLE BEHAVIOUR OF LIPID PROFILE IN CHOLELITHIATIC GALL BLADDER
In recent years, effort has been made to knowing the pathophysiological basis of gallstone formation. The role of serum lipids in the etiology of cholelithiasis is very important and in cholesterol gallstones serum lipid...
RED CELL DISTRIBUATION WIDTH, C- REACTIVE PROTEIN AND ESR IN MYOCARDIAL INFARACTION PATIENTS
Background: Myocardial Infarction is the cause of morbidity and mortality in Sudan. This study described altered Red Cell Distribution Width –SD (RDW-SD), Red Cell Distribution Width –CV (RDW-CV), C-reactive protein (CRP...